Reply from M. Frisk, D. B. Lipsett and W. E. Louch.

Autor: Frisk M; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, NO-0424, Oslo, Norway.; KG Jebsen Centre for Cardiac Research and Center for Heart Failure Research, University of Oslo, Oslo, Norway., Lipsett DB; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, NO-0424, Oslo, Norway.; KG Jebsen Centre for Cardiac Research and Center for Heart Failure Research, University of Oslo, Oslo, Norway., Louch WE; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, NO-0424, Oslo, Norway.; KG Jebsen Centre for Cardiac Research and Center for Heart Failure Research, University of Oslo, Oslo, Norway.

Publikováno v: The Journal of physiology [J Physiol] 2019 Jun; Vol. 597 (11), pp. 2967-2968. Date of Electronic Publication: 2019 May 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ProANP31-67 ameliorates adverse cardiac remodeling and improves systolic and diastolic functions in a preclinical model of cardiorenal syndrome

Autor: GJJ Silva, R Parvan, X Shen, M Frisk, R Altara, ME Strand, KB Rypdal, IG Lunde, WE Louch, JM Aronsen, K-O Stenslokken, MK Stokke, A Cataliotti

Publikováno v: Cardiovascular Research. 118

Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): South-Eastern Norway Regional Health Authority (HSØ-RHF, Project No. 25674) Background The cardiac hormone proANP31-67, a linear frag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::59ce2abd4565b6544a1043ba45f69c52
https://doi.org/10.1093/cvr/cvac066.080

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.